Journal
NANO TODAY
Volume 5, Issue 4, Pages 296-312Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.nantod.2010.06.007
Keywords
Drug delivery; Nanoparticles; Liver targeting; Hepatitis B virus infection; Liver fibrosis; Hepatocellular carcinoma (HCC)
Categories
Funding
- National Basic Research Program 973 of P.R. China [2007CB513003]
- Biomedical Research Council
- Institute of Bioengineering and Nanotechnology, Agency for Science, Technology and Research, Singapore
- National University of Singapore
Ask authors/readers for more resources
Liver diseases, particularly hepatitis B virus infections, liver cirrhosis and hepatocellular carcinoma continue to pose a significant health challenge worldwide due to the dire lack of curative treatment options besides liver resection and transplantation. Nanoparticle therapeutics, comprising of drugs, nucleic acids or proteins in association with a carrier, have emerged as safe and efficient systems in the treatment of the respective liver diseases. This review describes targeting strategies employed in relation to liver anatomy and disease etiologies, summarizes recent advances in the field and discusses the challenges and future perspectives for the effective treatment of liver diseases using polymer- and lipid-based nanoparticle therapeutics. (C) 2010 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available